PMID: 11918126Mar 29, 2002Paper

Chronic kidney disease: stating the managed care case for early treatment. Discussion and consensus of presentations of economic analyses, managed care organization case studies, and opportunities for intervention in a managed care setting. May 3-5, 2001 Chicago, Illinois

The American Journal of Managed Care

Abstract

Based on an analysis of data from the National Health and Nutrition Examination Survey, approximately 20 million people currently have some degree of decreased glomerular filtration rate or overt kidney disease. Despite numerous challenges to be overcome, managed care organizations and the nephrology community are seeking ways to collaborate in improving the quality of care of such patients. Using current data, as well as information about the cost of care, priority is being given to the establishment of early intervention programs to maximize the existing healthcare infrastructure and to improve the clinical outcomes of chronic kidney disease and end-stage renal disease.

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

EDTNA/ERCA Journal : Official Journal of the European Dialysis and Transplant Nurses Association, European Renal Care Association
N Thomas
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Smita GundaSteve Smith
American Journal of Nephrology
Michael J FischerElisa J Gordon
Nefrología : publicación oficial de la Sociedad Española Nefrologia
L M Lou ArnalGrupo de Investigación ERC Aragón
© 2022 Meta ULC. All rights reserved